Table 2.
Patient characteristics.
| Total | 3626 | |
|---|---|---|
| Characteristics | Number | % |
| Sex | ||
| Male | 2567 | 71 |
| Female | 1059 | 29 |
|
| ||
| Current age (years) | ||
| ≤35 | 1383 | 38 |
| 36–45 | 1449 | 40 |
| 46+ | 794 | 22 |
|
| ||
| Reported exposure | ||
| Heterosexual contact | 2337 | 64 |
| Homosexual contact | 749 | 21 |
| Injecting drug use | 263 | 7 |
| Other/unknown | 277 | 8 |
|
| ||
| Ethnicity | ||
| Chinese | 989 | 27 |
| Indian | 390 | 11 |
| Thai | 933 | 26 |
| Other/unknown | 1314 | 36 |
|
| ||
| Baseline CD4 count (cells/μl.) | ||
| ≤100 | 239 | 7 |
| 101–200 | 406 | 11 |
| 201+ | 2531 | 70 |
| Missing | 450 | 12 |
|
| ||
| Baseline HIV RNA (copies/ml) | ||
| ≤500 | 1482 | 41 |
| 501+ | 379 | 10 |
| Missing | 1765 | 49 |
|
| ||
| CDC disease stage at baseline | ||
| Stage A | 1621 | 45 |
| Stage B | 321 | 9 |
| Stage C | 1684 | 46 |
|
| ||
| Tuberculosis diagnosis at baseline | ||
| No | 2758 | 76 |
| Yes | 868 | 24 |
|
| ||
| Time since HIV infection (years) | ||
| ≤5 | 2295 | 63 |
| 6+ | 1246 | 34 |
| Missing | 85 | 2 |
|
| ||
| Hepatitis B infection | ||
| No | 2297 | 63 |
| Yes | 257 | 7 |
| Not tested | 1072 | 30 |
|
| ||
| Hepatitis C infection | ||
| No | 2007 | 55 |
| Yes | 324 | 9 |
| Not tested | 1295 | 36 |
|
| ||
| Anemia at baseline | ||
| No | 2480 | 68 |
| Yes | 597 | 16 |
| Haemoglobin not tested | 567 | 16 |
| Antiretroviral treatment at baseline | ||
| 3 + (NRTI + NNRTI) | 2224 | 61 |
| 3 + (NRTI + PI) | 744 | 21 |
| No/mono/double drug | 583 | 16 |
| 3 + (other combination) | 75 | 2 |
Anemia: haemoglobin <13 g/dl (male), <11 g/dl (female); NRTI: nucleoside reverse transcriptase inhibitor; NNRTI: nonnucleoside reverse transcriptase inhibitor; PI: protease inhibitor.